title: Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression.
authors.affiliation: Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Oki
authors.affiliation: Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: D
authors.initials: D
authors.lastname: Buglio
authors.affiliation: Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: J
authors.initials: J
authors.lastname: Zhang
authors.affiliation: Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Ying
authors.affiliation: Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: S
authors.initials: S
authors.lastname: Zhou
authors.affiliation: Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Sureda
authors.affiliation: Hematology Division, Hadassah Medical Organization, Jerusalem, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Ben-Yehuda
authors.affiliation: Institute of Hematology and Medical Oncology, University of Bologna, Bologna, Italy.
authors.forename: P L
authors.initials: PL
authors.lastname: Zinzani
authors.affiliation: Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia.
authors.forename: H M
authors.initials: HM
authors.lastname: Prince
authors.affiliation: Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia.
authors.forename: S J
authors.initials: SJ
authors.lastname: Harrison
authors.affiliation: Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Kirschbaum
authors.affiliation: Department of Hematology, Mayo Clinic, Rochester, MN, USA.
authors.forename: P B
authors.initials: PB
authors.lastname: Johnston
authors.affiliation: Novartis Pharmaceuticals, Florham Park, NJ, USA.
authors.forename: A
authors.initials: A
authors.lastname: Shen
authors.affiliation: University Hospital of Cologne, Cologne, Germany.
authors.forename: B
authors.initials: B
authors.lastname: von Tresckow
authors.affiliation: Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: A
authors.initials: A
authors.lastname: Younes
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016207:Cytokines / Q000097:blood / Q000276:immunology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects / Q000276:immunology; D006689:Hodgkin Disease / Q000097:blood / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage*; D007211:Indoles / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000097:blood / Q000276:immunology; D000077767:Panobinostat; D061026:Programmed Cell Death 1 Receptor / Q000096:biosynthesis / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D016207:Cytokines; D006877:Hydroxamic Acids; D007211:Indoles; D009363:Neoplasm Proteins; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D000077767:Panobinostat
references.citation: PLoS One. 2013 Nov 21;8(11):e79502
references.pmid: 24278143
references.citation: N Engl J Med. 2012 Jun 28;366(26):2455-65
references.pmid: 22658128
references.citation: Blood. 2011 Mar 10;117(10):2910-7
references.pmid: 21239696
references.citation: J Pathol. 2010 Jul;221(3):248-63
references.pmid: 20527019
references.citation: J Clin Oncol. 2007 Feb 10;25(5):579-86
references.pmid: 17242396
references.citation: Leuk Lymphoma. 2014 May;55(5):1053-60
references.pmid: 23822537
references.citation: J Clin Oncol. 2013 Nov 20;31(33):4199-206
references.pmid: 24127452
references.citation: J Clin Oncol. 2012 Jun 20;30(18):2197-203
references.pmid: 22547596
references.citation: N Engl J Med. 2013 Jul 11;369(2):134-44
references.pmid: 23724846
references.citation: J Clin Oncol. 2011 May 10;29(14):1812-26
references.pmid: 21483001
references.citation: Leuk Lymphoma. 2013 May;54(5):967-72
references.pmid: 23020783
references.citation: Clin Cancer Res. 2013 Dec 15;19(24):6812-9
references.pmid: 24141626
references.citation: Lancet Oncol. 2014 Jan;15(1):69-77
references.pmid: 24332512
references.citation: Semin Cancer Biol. 2014 Feb;24:15-22
references.pmid: 23867303